MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$5.82
Tradestie Score
39
Market Cap
$719.23M
Revenue Growth
-0.1%
Analyst Upside
-22.9%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$132.55
|
$2.24B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.51
|
$2.22B | - | 66 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$139.92
|
$1.77B | - | 57 | Compare |
|
NEOG
Neogen Corp
|
$12.19
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.63
|
$1.23B | - | 37 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.59
|
$1.13B | - | 63 | Compare |
|
CDNA
CareDx, Inc.
|
$69.21
|
$798.40M | 34.1 | 23 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.10
|
$719.31M | - | 58 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$33.08
|
$667.77M | - | 59 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.85
|
$612.76M | - | 54 | Compare |
More MYGN Analysis
Data updated: Oct 23, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry